Edinburgh, Midlothian
United Kingdom
7
2022-12-15
6
2020-03-17
These are the the leading inventors for applications assigned to IOmet Pharma Ltd.:
IOmet Pharma Ltd. based in Edinburgh, Midlothian, GB has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:
NOVEL SUBSTITUTED 1,3-8-TRIAZASPIRO[4,5] DECANE-2,4-DIONE COMPOUNDS AS INDOLEAMINE 2,3-DIOXYGENASE (IDO) AND/OR TRYPTOPHAN 2,3-DIOXYGENASE (TDO) INHIBITORS
#2 | 2018-12-13 ✅ Patent 10,590,086 granted on 2020-03-17Pharmaceutical compound
#3 | 2018-02-08 ✅ Patent 10,287,252 granted on 2019-05-14Inhibitors of tryptophan-2,3-dioxygenase or indoleamine-2,3-dioxygenase
#4 | 2017-09-21 ✅ Patent 10,047,074 granted on 2018-08-14Pharmaceutical compound
#5 | 2017-04-20 ✅ Patent 10,167,257 granted on 2019-01-01Indole derivatives for use in medicine
#6 | 2017-01-12 ✅ Patent 10,155,972 granted on 2018-12-18Screening method
#7 | 2016-12-22 ✅ Patent 9,931,347 granted on 2018-04-03Pharmaceutical compound
Also check out IOmet Pharma Ltd.'s (Edinburgh, Midlothian, United Kingdom) applicant profile with 6 patent applications submitted.
116797 ⎘